A question about potential share price. Looking at Moderna and Novarax it’s pretty clear that IF the efficacy results are great, and IF the government agencies smile upon us there is potential.
How much potential?
NP has been quoted as saying 3 figures. If fact high 3 figures was mentioned several times.
Now I’m assuming this is based on many indications in addition to CV19, but are these statements based on truth, or are they merely the prognostications of an exuberant CEO selling his stock?

On a happy note I did come across this article while I was looking at Novarax. The line about how much the shorts lost made me smile.

https://www.bloomberg.com/news/articles/2020-...first-test